BIOLASE Stock Forecast for 2023 - 2025 - 2030

Updated on 04/27/2024

Stock Rating
0
Price Target
$0.50
Consensus
Outperform
Upside
233.33%
Analysts
0
Stock Rating
0
Upside
233.33%
Analysts
0
Price Target
$0.50

BIOLASE Stock Forecast and Price Target

The average price target for BIOLASE's stock set by recognized analysts recently is $0.50, which would result in a potential upside of approximately 233.33% if it reached this mark. The estimation is based on a high estimate of $4.00 and a low estimate of $0.40. Even if you are not interested in BIOL stock, you should be aware of its competitors and their current standings.

$0.50

233.33% Upside

Buy
Buy

BIOLASE Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, BIOLASE's Price has grown by 100.00%, from $0.00 to $0.00. For the next year, analysts are expecting Fair Value to reach $0.16 – an increase of 100.00%. Over the next seven years, experts predict that Fair Value will grow by 100.00%.

2024 Fair Value Forecast
$0.16
2025 Fair Value Forecast
$0.18
2026 Fair Value Forecast
$0.20
2027 Fair Value Forecast
$0.22
2028 Fair Value Forecast
$0.25
2029 Fair Value Forecast
$0.27
2030 Fair Value Forecast
$0.30

BIOLASE Revenue Forecast for 2023 - 2025 - 2030

In the last two years, BIOLASE's Revenue has grown by 112.73%, from $22.78M to $48.46M. For the next year, analysts are expecting Revenue to reach $63.71M – an increase of 31.47%. Over the next seven years, experts predict that Revenue will grow by 11.87%.

2024 Rev Forecast
$0.06B
2025 Rev Forecast
$0.06B
2026 Rev Forecast
$0.05B
2027 Rev Forecast
$0.05B
2028 Rev Forecast
$0.05B
2029 Rev Forecast
$0.06B
2030 Rev Forecast
$0.05B

BIOLASE Dividend per Share Forecast for 2023 - 2025 - 2030

BIOLASE Free Cash Flow Forecast for 2023 - 2025 - 2030

BIOLASE EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, BIOLASE's EBITDA has grown by 37.69%, rising from $-18.04M to $-24.84M. In the next year, 2 analysts estimate that BIOLASE's EBITDA will decrease by 95.77%, reaching $-1.05M. Over the next seven years, experts predict that BIOLASE's EBITDA will grow at a rate of 18.91%.

2024 EBITDA Forecast
$-1050000.00
2025 EBITDA Forecast
$450.00k
2026 EBITDA Forecast
$0.00B
2027 EBITDA Forecast
$0.02B
2028 EBITDA Forecast
$-16171947.58
2029 EBITDA Forecast
$-20132457.54
2030 EBITDA Forecast
$-29537670.62

BIOLASE EBIT Forecast for 2023 - 2025 - 2030

In the last two years, BIOLASE's EBIT has grown, rising from $-18.54M to $-25.34M – a growth of 36.68%. According to 4 analysts, BIOLASE's EBIT will fall by 88.60% in the next year, reaching $-2.89M. Professionals believe that By 2030, BIOLASE's EBIT will fall to $-18.43M – a 27.25% decrease from its current value.

2024 EBIT Forecast
$-2890000.00
2025 EBIT Forecast
$-3240000.00
2026 EBIT Forecast
$-11145600.00
2027 EBIT Forecast
$-36969583.68
2028 EBIT Forecast
$-18290085.37
2029 EBIT Forecast
$-15933712.70
2030 EBIT Forecast
$-18433712.22

BIOLASE EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, BIOLASE's EPS has grown by 100.00%, from $-1400.00 to $0.00. For the next year, analysts are expecting EPS to reach $-0.94 – an increase of 100.00%. Over the next seven years, experts predict that EPS will grow by 100.00%.

2024 EPS Forecast
$-0.94
2025 EPS Forecast
$0.03
2026 EPS Forecast
$-0.29
2027 EPS Forecast
$2.86
2028 EPS Forecast
$-27.95
2029 EPS Forecast
$-38.21
2030 EPS Forecast
$-34.79